Advertisement

Hypercalciurias

  • Charles Y. C. Pak
Part of the Topics in Bone and Mineral Disorders book series (TOHE)

Abstract

Hypercalciuria is probably the most common biochemical abnormality in patients with Ca urolithiasis.1–3 Although reported estimates vary, hypercalciuria may be found in the majority of patients suffering from Ca stones. Because of this high incidence, the excessive renal excretion of Ca has been considered to be etiologically important in stone formation. Thus, considerable work has been directed toward the delineation of pathogenesis, diagnostic criteria, and treatment of hypercalciuria.

Keywords

Primary Hyperparathyroidism Stone Formation Calcium Oxalate Urinary Oxalate Idiopathic Hypercalciuria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pak, C. Y. C., Barilla, D., Bone, H., and Northcutt, C. 1977. Medical management of renal calculi. In New Concepts in Endocrinology and Metabolism. L. I. Rose and R. L. Levine, Eds. Grune and Stratton, New York, pp. 97–106.Google Scholar
  2. 2.
    Hodgkinson, A., and Pyrah, L. N. 1958. The urinary calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br. J. Surg. 46: 10–18.PubMedCrossRefGoogle Scholar
  3. 3.
    Pak, C. Y. C., Ohata, M., Lawrence, E. C., and Snyder, W. 1974. The hypercalciurias: Causes, parathyroid functions and diagnostic criteria. J. Clin. Invest. 54: 387–400.PubMedCrossRefGoogle Scholar
  4. 4.
    Pak, C. Y. C. 1969. Physiochemical basis for the formation of renal stones of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite. J. Clin. Invest. 48: 1914–1922.PubMedCrossRefGoogle Scholar
  5. 5.
    Pak, C. Y. C., and Holt, K. 1976. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25: 665–673.PubMedCrossRefGoogle Scholar
  6. 6.
    Czekalski, S., Loreau, N., Paillard, F., Ardaillou, R., Fillastre, J.-P., and Mallet, E. 1974. Effect of bovine parathyroid hormone 1–34 fragment on renal production and excretion of adenosine 3’,5’ monophosphate in man. Eur. J. Clin. Invest. 4: 85–92.Google Scholar
  7. 7.
    Pak, C. Y. C., Cox, J. W., Powell, E., and Bartter, F. C. 1971. Effect of the oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine. Am. J. Med. 50: 67–76.PubMedCrossRefGoogle Scholar
  8. 8.
    Robertson, W. G., Peacock, M., and Nordin, B. E. C. 1971. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin. Sci. 40: 365–374.PubMedGoogle Scholar
  9. 9.
    Parfitt, A. M., Higgins, B. A., Nassim, J. R., Collins, J. A., and Hilb, A. 1964. Metabolic studies in patients with hypercalciuria. Clin. Sci. 27: 463–482.PubMedGoogle Scholar
  10. 10.
    Murphy, G. P., and Schirmer, H. K. 1961. Nephrocalcinosis, urolithiasis and renal insufficiency in sarcoidosis. J. Urol. 86: 702–706.PubMedGoogle Scholar
  11. 11.
    Forbes, A. P., and Dempsey, E. 1963. Nephrolithiasis Diseases of the Kidney. M. B. Strauss and L. G. Welt, Eds. Little, Brown, Boston, pp. 714–727.Google Scholar
  12. 12.
    Kaplan, R. A., Snyder, W. H., Stewart, A., and Pak, C. Y. C. 1976. Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 42: 415–426.PubMedCrossRefGoogle Scholar
  13. 13.
    Howard, J. E., Thomas, W. C., Jr., Mukai, T., Johnston, R. A., Jr., and Pascoe, B. J. 1962. The calcification of cartilage by urine, and a suggestion for therapy in patients with certain kinds of calculi. Trans. Assoc. Am. Physicians 75: 301–305.PubMedGoogle Scholar
  14. 14.
    Smith, L. H., Meyer, J. L., and McCall, J. T. 1973. Chemical nature of crystal inhibitors isolated from human urine. In Urinary Calculi: Proceedings of the International Symposium on Renal Stone Research, Madrid, 1972. L. Cifiientes Delatte, A. Rapado, and A. Hodgkinson, Eds. S. Karger, Basel and New York, pp. 318–327.Google Scholar
  15. 15.
    Takasaki, E. 1972. The magnesium:calcium ratio in the concentrated urines of patients with calcium oxalate calculi. Invest. Urol. 10: 147–150.PubMedGoogle Scholar
  16. 16.
    Mcintosh, H. W., and Seraglia, M. 1963. Urinary excretion of calcium and citrate in normal individuals and stone formers with variation in calcium intake. Can. Med. Assoc. J. 89: 1242–1243.PubMedGoogle Scholar
  17. 17.
    Revusova, V., Zvara, V., and Gratzlova, J. 1973. Urinary zinc excretion in patients with urolithiasis. Urol. Int. 28: 72–79.PubMedCrossRefGoogle Scholar
  18. 18.
    Robertson, W. G., Knowles, F., and Peacock, M. 1976. Urinary acid mucopolysaccharide inhibitors of calcium oxalate crystallization. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 331–334.CrossRefGoogle Scholar
  19. 19.
    Fleisch, H. 1977. Personal communication.Google Scholar
  20. 20.
    Finlayson, B., and Roth, R. 1973. Appraisal of calcium oxalate solubility in sodium chloride and sodium-calcium chloride solutions. Urology 1: 142–144.PubMedCrossRefGoogle Scholar
  21. 21.
    Williams, H. E., 1976. Oxalic acid: Absorption, excretion and metabolism. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 181–188.CrossRefGoogle Scholar
  22. 22.
    Earnest, D. L., Williams, H. E., and Admirand, W. H. 1975. A physicochemical basis for treatment of enteric hyperoxaluria. Trans. Assoc. Am. Physicians. 88: 224–234.PubMedGoogle Scholar
  23. 23.
    Pak, C. Y. C., East, C., Sanzenbacher, L. J., Delea, C. S., and Bartter, F. C. 1972. Gastrointestinal calcium absorption in nephrolithiasis. J. Clin. Endocrinol. Metab. 35: 261–270.PubMedCrossRefGoogle Scholar
  24. 24.
    Pak, C. Y. C. 1976. Idiopathic renal lithiasis: New developments in evaluation and treatment. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 213–224.CrossRefGoogle Scholar
  25. 25.
    Nordin, B. E. C., Peacock, M., and Wilkinson, R. 1972. Hypercalciuria and calcium stone disease. In Clinics in Endocrinol, and Metabolism. I. Mclntyre, Ed. W. B. Saunders, Philadelphia, pp. 169–183.Google Scholar
  26. 26.
    Coe, F. L., Canterbury, J. M., Firpo, J. J., and Reiss, E. 1973. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J. Clin. Invest. 52: 134–142.PubMedCrossRefGoogle Scholar
  27. 27.
    Agus, Z. S., Gardner, L. B., Beck, L. H., and Goldberg, M. 1973. Effects of parathyroid hormone on renal tubular reabsorption of calcium, sodium, and phosphate. Am. J. Physiol. 224: 1143–1148.PubMedGoogle Scholar
  28. 28.
    Pak, C. Y. C., Kaplan, R. A., Bone, H., Townsend, J., and Waters, O. 1975. A simple test for the diagnosis of absorptive, resorptive, and renal hypercalciurias. N. Engl. J. Med. 292: 497–500.PubMedCrossRefGoogle Scholar
  29. 29.
    Barilla, D., Tolentino, R., Kaplan, R. A., and Pak, C. Y. C. Selective effect of thiazide on the intestinal absorption of calcium in absorptive and renal hypercalciurias. Metabolism. In press.Google Scholar
  30. 30.
    Henneman, P. H., Benedict, P. H., Forbes, A. P., and Dudley, H. R. 1958. Idiopathic hypercalciuria. N. Engl. J. Med. 259: 802–807.PubMedCrossRefGoogle Scholar
  31. 31.
    Nordin, B. E. C., Peacock, M., and Marshall, D. H. 1976. Calcium excretion and hypercalciuria. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 101–115.CrossRefGoogle Scholar
  32. 32.
    Shen, F., Baylink, D., Nielson, R., Hughes, M., and Haussler, M. 1975. Increased serum 1,25-dihydroxycholecalciferol (l,25-diOHD3) in patients with idiopathic hypercalciuria (IH). Clin. Res. 23A: 423.Google Scholar
  33. 33.
    Lemann, J., Gray, R. W., and Dominguez, J. H. 1976. 25-OH-vitamin D metabolism in calcium stone formers. In Urolithiasis Research. H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, Eds. Plenum Press, New York, pp. 467–472.Google Scholar
  34. 34.
    Albright, F., Henneman, P., Benedict, P. H., and Forbes, A. P., 1953. Idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 13: 860.Google Scholar
  35. 35.
    Liberman, U. A., Sperling, O., Atsmon, A., Frank, M., Modan, M., and deVries, A. 1968. Metabolic and calcium kinetics studies in idiopathic hypercalciuria. J. Clin. Invest. 47: 2580–2590.PubMedCrossRefGoogle Scholar
  36. 36.
    Edwards, N. A., and Hodgkinson, A. 1965. Metabolic studies in patients with idiopathic hypercalciuria. Clin. Sei. 29: 143–157.Google Scholar
  37. 37.
    Peacock, M., Hodgkinson, A., and Nordin, B. E. C. 1967. Importance of dietary calcium in the definition of hypercalciuria. Br. Med. J. 3: 469–471.PubMedCrossRefGoogle Scholar
  38. 38.
    Dent, C. E., Harper, M., and Parfitt, A. M. 1964. The effect of cellulose phosphate on calcium metabolism in patients with hypercalciuria. Clin. Sei. 27: 417–425.Google Scholar
  39. 39.
    Peacock, M., and Nordin, B. E. C. 1968. Tubular reabsorption of calcium in normal and hypercalciuric subjects. J. Clin. Pathol. 21: 353–358.PubMedCrossRefGoogle Scholar
  40. 40.
    Finn, W. F., Cerilli, G. J., and Ferris, T. F. 1970. Transplantation of a kidney from a patient with idiopathic hypercalciuria. N. Engl. J. Med. 283: 1450–1451.PubMedCrossRefGoogle Scholar
  41. 41.
    Pronove, P., Bell, N. H., and Bartter, F. C. 1961. Production of hypercalciuria by phosphorus deprivation on a low calcium intake: A new clinical test for hyperparathyroidism. Metabolism 10: 364–371.PubMedGoogle Scholar
  42. 42.
    Pak, C. Y. C. 1972. Effects of cellulose phosphate and of sodium phosphate on the formation product and activity product of brushite in urine. Metabolism 21: 447–453.PubMedCrossRefGoogle Scholar
  43. 43.
    Wills, M. R., Gill, J. R., Jr., and Bartter, F. C. 1969. The interrelationships of calcium and sodium excretions. Clin. Sei. (Oxford) 37: 621–630.Google Scholar
  44. 44.
    McCance, R. A., Widdowson, E. M., and Lehmann, H. 1942. The effect of protein intake on the absorption of calcium and magnesium. Biochem. J. 36: 686–691.PubMedGoogle Scholar
  45. 45.
    Murad, F., and Pak, C. Y. C. 1972. Urinary excretion of adenosine 3’,5’- monophosphate and guanosine 3’,5’-monophosphate. N. Engl. J. Med. 286: 1382–1387.PubMedCrossRefGoogle Scholar
  46. 46.
    Shaw, J. W., Oldham, S. B., Rosoff, L., Bethune, J. E., and Fichman, M. P. 1977. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the differential diagnosis of hypercalcemia. J. Clin. Invest. 59: 14–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Arnaud, C. D., Hang, S. T., and Littledike, T. 1971. Radioimmunoassay of human parathyroid hormone in serum. J. Clin. Invest. 50: 21–34.PubMedCrossRefGoogle Scholar
  48. 48.
    Reiss, E., and Canterbury, J. M. 1969. Primary hyperparathyroidism. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N. Engl. J. Med. 280: 1381–1385.PubMedCrossRefGoogle Scholar
  49. 49.
    Bell, N. H., Gill, J. R., Jr., and Bartter, F. C. 1964. On the abnormal calcium absorption in sarcoidosis. Am. J. Med. 36: 500–513.PubMedCrossRefGoogle Scholar
  50. 50.
    Lemann, J., Jr., Litzow, J. R., and Lennon, E. J. 1967. Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J. Clin. Invest. 46: 1318–1328.PubMedCrossRefGoogle Scholar
  51. 51.
    Kaplan, R. A., Haussler, M. R., Deftos, L. J., Bone, H., and Pak, C. Y. C. The role of la,25-dihydroxycholecalciferol in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Invest. 59: 756–760.Google Scholar
  52. 52.
    McGeown, M. D. 1960. Heredity in renal stone disease. Clin. Sci. 19: 465–471.PubMedGoogle Scholar
  53. 53.
    Resnick, M., Pridgen, D. B., and Goodman, H. O. 1968. Genetic disposition to formation of calcium oxalate renal calculi. N. Engl. J. Med. 278: 1313–1318.PubMedCrossRefGoogle Scholar
  54. 54.
    Haussler, M. R., Bursac, K. M., Bone, H., and Pak, C. Y. C. 1975. Increased circulating 1 a,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Clin. Res. 23: 322A.Google Scholar
  55. 55.
    Garabedian, M., Holick, M. F., DeLuca, H. F., and Boyle, I. T. 1973. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc. Natl. Acad. Sci. U.S.A. 69: 1673–1676.CrossRefGoogle Scholar
  56. 56.
    Hughes, M. R., Brumbaugh, P. F., Haussler, M. R., Wergedal, J. E., and Baylink, D. J. 1975. Regulation of serum la,25-dihydroxyvitamin D by calcium and phosphate in the rat. Science 190: 578–580.PubMedCrossRefGoogle Scholar
  57. 57.
    Pak, C. Y. C. 1973. Sodium cellulose phosphate: Mechanism of action and effect on mineral metabolism. J. Clin. Pharmacol. 13: 15–27.Google Scholar
  58. 58.
    Hayashi, Y., Kaplan, R. A., and Pak, C. Y. C. 1975. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism 24: 1273–1278.PubMedCrossRefGoogle Scholar
  59. 59.
    Marshall, R. W., and Barry, H. 1972. Urine saturation and the formation of calcium-containing renal calculi: The effects of various forms of therapy. In Urinary Calculi: Proceedings of the International Symposium on Renal Stone Research, Madrid, 1972. L. Cifuentes Delatte, A. Rapado, and A. Hodgkinson, Eds. Karger, Basel and New York, pp. 164–169.Google Scholar
  60. 60.
    Rapado, A., Delatte, L. C., Villarino, J. A., and Sanchez-Martin, J. A. 1970. Treatment of idiopathic hypercalciuria with sodium cellulose phosphate. Rev. Clin. Esp. 119: 61–66.PubMedGoogle Scholar
  61. 61.
    Rose, A. G., and Harrison, A. R. 1974. The incidence, investigation, and treatment of idiopathic hypercalciuria. Br. J. Urol. 46: 261–274.PubMedCrossRefGoogle Scholar
  62. 62.
    Blacklock, N. J., and MacLeod, M. A. 1974. The effect of cellulose phosphate on intestinal absorption and urinary excretion of calcium. Br. J. Urol. 46: 385–392.PubMedCrossRefGoogle Scholar
  63. 63.
    Pak, C. Y. C., Delea, C. S., and Bartter, F. C. 1974. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N. Engl. J. Med. 290: 175–180.PubMedCrossRefGoogle Scholar
  64. 64.
    Pak, C. Y. C., Wortsman, J., Bennett, J. E., Delea, C. S., and Bartter, F. C. 1968. Control of hypercalcemia with cellulose phosphate. J. Clin. Endocrinol. Metab. 28: 1829–1832.CrossRefGoogle Scholar
  65. 65.
    Yendt, E. R., Guay, G. F., and Garcia, D. A. 1970. The use of thiazides in the prevention of renal calculi. Can. Med. Assoc. J. 102: 614–620.PubMedGoogle Scholar
  66. 66.
    Lamberg, B. A., and Kuhlback, B. 1959. Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in the urine. Scand. J. Clin. Lab. Invest. 11: 351–357.PubMedCrossRefGoogle Scholar
  67. 67.
    Middler, S., Pak, C. Y. C., Murad, F., and Bartter, F. C. 1973. Thiazide diuretics and calcium metabolism. Metabolism 22: 139–146.PubMedCrossRefGoogle Scholar
  68. 68.
    Brickman, A. S., Massry, S. G., and Coburn, J. W. 1972. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms. J. Clin. Invest. 51: 945–954.PubMedCrossRefGoogle Scholar
  69. 69.
    Pak, C. Y. C. 1973. Hydrochlorothiazide therapy in nephrolithiasis: Effect on urinary activity product and formation product of brushite. Clin. Pharmacol. Ther. 14: 209–217.PubMedGoogle Scholar
  70. 70.
    Pak, C. Y. C., Ruskin, B., and Diller, E. 1972. Enhancement of renal excretion of zinc by hydrochlorothiazide. Clin. Chim. Acta 39: 511–517.PubMedCrossRefGoogle Scholar
  71. 71.
    Cohanim, M., and Yendt, E. R. 1975. The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med. J. 136: 137–141.PubMedGoogle Scholar
  72. 72.
    Pickelman, J., Payloyan, F., Forland, M., and Strauss, F. H. 1968. Thiazide induced parathyroid stimulation. Clin. Res. 16: 468.Google Scholar
  73. 73.
    Costanzo, L. S., Moses, A. M., Janardhana Rao, K., and Weiner, I. M. 1975. Dissociation of calcium and sodium clearances in patients with hypoparathyroidism by infusion of chlorothiazide. Metabolism 24: 1367–1373.PubMedCrossRefGoogle Scholar
  74. 74.
    Costanzo, L. S., and Weiner, I. M. 1974. On the hypocalciuric action of chlorothiazide. J. Clin. Invest. 54: 628–637.PubMedCrossRefGoogle Scholar
  75. 75.
    Woelfel, A., Kaplan, R. A., and Pak, C. Y. C. 1977. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine. Metabolism 26: 201–205.PubMedCrossRefGoogle Scholar
  76. 76.
    Gursel, E. 1970. Effects of diuretics on renal and intestinal handling of calcium. N. Y. State J. Med. 70: 399–405.PubMedGoogle Scholar
  77. 77.
    Duarte, C. G., Winnacker, J. L., Becker, K. L., and Pace, A. 1971. Thiazide-induced hypercalcemia. N. Engl. J. Med. 284: 828–830.PubMedCrossRefGoogle Scholar
  78. 78.
    Parfitt, A. M. 1969. Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N. Engl. J. Med. 281: 55–59.PubMedCrossRefGoogle Scholar
  79. 79.
    Banks, P. A. 1971. Acute pancreatitis. Gastroenterology 61: 382–397.PubMedGoogle Scholar
  80. 80.
    Forland, M., Strandjord, N. M., Paloyan, E., and Cox, A. 1968. Bone density studies in primary hyperparathyroidism. Arch. Intern. Med. 122: 236–240.PubMedCrossRefGoogle Scholar
  81. 81.
    Fleisch, H., Bisaz, S., and Care, A. D. 1964. Effect of orthophosphate on urinary pyrophosphate excretion and the prevention of urolithiasis. Lancet 1: 1065–1067.PubMedCrossRefGoogle Scholar
  82. 82.
    Reiss, E., Canterbury, J. M., Bercovitz, M. A., and Kaplan, E. L. 1970. The role of phosphate in the secretion of parathyroid hormone in man. J. Clin. Invest. 40: 2146–2149.CrossRefGoogle Scholar
  83. 83.
    Smith, L. H., Thomas, W. C., Jr., and Arnaud, C. D. 1972. Orthophosphate therapy in calcium renal lithiasis. In Urinary Calculi: Proceedings of the International Symposium on Renal Stone Research, Madrid, 1972. L. Cifuentes Delatte, A. Rapado, and A. Hodgkinson, Eds. Karger, Basel and New York, pp. 188–197.Google Scholar
  84. 84.
    Raisz, L. G., and Niemann, I. 1969. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 85: 446–452.PubMedCrossRefGoogle Scholar
  85. 85.
    Spaulding, S. W., and Walser, M. 1970. Treatment of experimental hypercalcemia with oral phosphate. J. Clin. Endocrinol. 31: 531–538.CrossRefGoogle Scholar
  86. 86.
    Dudley, F. J., and Blackburn, C. R. B. 1970. Extraskeletal calcification complicating oral neutralphosphate therapy. Lancet 2: 628–630.PubMedCrossRefGoogle Scholar
  87. 87.
    Pak, C. Y. C. 1977. Idiopathic hypercalciuria. In Advances in Experimental Medicine and Biology, Vol. 81: Phosphate Metabolism. S. G. Massry and E. Ritz, Eds. Plenum, New York, pp. 309–317.Google Scholar
  88. 88.
    Bernstein, D. S., and Newton, R. 1966. The effect of oral sodium phosphate on the formation of renal calculi and on idiopathic hypercalciuria. Lancet 2: 1105–1107.PubMedCrossRefGoogle Scholar
  89. 89.
    Ettinger, B., and Kolb, F. 1973. Inorganic phosphate treatment of nephrolithiasis. Am. J. Med. 55: 32–37.PubMedCrossRefGoogle Scholar
  90. 90.
    Ettinger, B. 1976. Recurrent nephrolithiasis: Natural history and effect of phosphate therapy. A double-blind control study. Am. J. Med. 61: 200–206.PubMedCrossRefGoogle Scholar
  91. 91.
    Jowsey, J., Reiss, E., and Canterbury, J. M. 1974. Longterm effects of high phosphate intake on parathyroid hormone levels and bone metabolism. Acta Orthop. Scand. 45: 801–808.PubMedCrossRefGoogle Scholar
  92. 92.
    Goldsmith, R. S., Jowsey, J., Dube, W. J., Riggs, B. L., Arnaud, C. D., and Kelly, P. J. 1976. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis. J. Clin. Endocrinol. Metab. 43: 523–532.PubMedCrossRefGoogle Scholar
  93. 93.
    Francis, M. D. 1969. The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates. Calcif. Tissue Res. 3: 151–162.PubMedCrossRefGoogle Scholar
  94. 94.
    Michael, W. R., King, W. R., and Wakim, J. M. 1972. Metabolism of disodium ethane-l-hydroxy-l,l-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey. Toxicol. Applied Pharmacol. 21: 503–515.CrossRefGoogle Scholar
  95. 95.
    Ohata, M., and Pak, C. Y. C. 1974. Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate. Metabolism 23: 1167–1173.CrossRefGoogle Scholar
  96. 96.
    Recker, R. R., Hassing, G. S., Lau, J. R., and Saville, P. D. 1973. The hyperphosphatemic effect of disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP™): Renal handling of phosphorus and the renal response to parathyroid hormone. J. Lab. Clin. Med. 81: 258–266.PubMedGoogle Scholar
  97. 97.
    Kaplan R. A., Geho, W. B., Poindexter, C., Haussler, M., Dietz, G. W., and Pak, C. Y. C. Metabolic effects of diphosphonate in primary hyperparathyroidism. J. Clin. Pharmacol. 17: 410–419.Google Scholar
  98. 98.
    Hill, L. F., Lumb, G. A., Mawer, E. B., and Stanbury, S. W. 1973. Indirect inhibition of the biosynthesis of 1,25–dihydroxycholecalciferol in rats treated with a diphosphonate. Clin. Sci. 44: 335–347.PubMedGoogle Scholar
  99. 99.
    Ohata, M., and Pak, C. Y. C. 1973. The effect of diphosphonate on calcium phosphate crystallization in urine in vitro. Kidney Int. 4: 401–406.CrossRefGoogle Scholar
  100. 100.
    Fraser, D., Russell, R. G. G., Pohler, O., Robertson, W. G., and Fleisch, H. 1972. The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin. Sci. 42: 197–207.PubMedGoogle Scholar
  101. 101.
    Pak, C. Y. C., Ohata, M., and Holt, K. 1975. Effect of diphosphonate on crystallization of calcium oxalate in vitro. Kidney Int. 7: 154–160.PubMedCrossRefGoogle Scholar
  102. 102.
    Robertson, W. G., Peacock, M., Marshall, R. W., and Knowles, F. 1974. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stone-formers. Clin. Sci. Mol. Med. 27: 13–22.Google Scholar
  103. 103.
    Pak, C. Y. C. 1977. Physicochemical and clinical aspects of nephrolithiasis. Proceedings of an International Colloquium on Renal Lithiasis. B. Finlayson and W. C. Thomas, Jr., Eds. University of Florida Press, Gainesville, pp. 257–275.Google Scholar
  104. 104.
    Francis, M. D., Russell, R. G. G., and Fleisch, H. 1969. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165: 1264–1266.PubMedCrossRefGoogle Scholar
  105. 105.
    Bone, H., Britton, F., and Pak, C. Y. C. In preparation.Google Scholar
  106. 106.
    Jowsey, J., Holley, K. E., and Lemann, J. W. 1970. Effect of sodium etidronate on adult cats. J. Lab. Clin. Med. 76: 126–133.PubMedGoogle Scholar
  107. 107.
    Sutor, D. J. 1969. Growth studies of calcium oxalate in the presence of various ions and compounds. Br. J. Urol. 41: 171–178.PubMedCrossRefGoogle Scholar
  108. 108.
    Meyer, J. L., and Smith, L. H. 1975. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest. Urol. 13: 36–39.PubMedGoogle Scholar
  109. 109.
    Fetner, C., Barilla, D. E., and Pak, C. Y. C. In preparation.Google Scholar
  110. 110.
    Barilla, D. E., Notz, C., Kennedy, D., and Pak, C. Y. C. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias: Effect of calcium and magnesium. Am. J. Med. In press.Google Scholar
  111. 111.
    Hammersten, G. 1956. Etiologic Factor in Renal Lithiasis. A. J. Pruitt, Ed. Charles C. Thomas, Springfield, Illinois, pp. 96.Google Scholar
  112. 112.
    Dobbins, J. W., and Binder, H. J. 1977. Importance of the colon in enteric hyperoxaluria. N. Engl. J. Med. 296: 298–301.PubMedCrossRefGoogle Scholar
  113. 113.
    Clark, I. 1969. Effects of magnesium on calcium and phosphate metabolism in parathyroidectomized rats. Endocrinology 85: 1103–1113.PubMedCrossRefGoogle Scholar
  114. 114.
    Pak, C. Y. C., and Diller, E. C. 1969. Ionic interaction with bone mineral. V. Effect of Mg2+, citrate3-, F-, and S042- on the solubility, dissolution and growth of bone mineral. Calcif. Tissue Res. 4: 69–77.PubMedCrossRefGoogle Scholar
  115. 115.
    Chase, L. R., and Slatopolsky, E. 1974. Secretion and metabolic efficacy of parathyroid hormone in patients with severe hypomagnesemia. J. Clin. Endocrinol. Metab. 38: 363–371.PubMedCrossRefGoogle Scholar
  116. 116.
    Pak, C. Y. C. 1973. Calcareous renal stones. Medcom Famous Teaching in Medicine. Medcom, New York, pp. 1–35.Google Scholar
  117. 117.
    Murphy, F. J., Zelman, S., and Mau, W. 1965. Ascorbic acid as a urinary acidifying agent. 2. Its adjunctive role in chronic urinary infection. J. Urol. 94: 300–303.PubMedGoogle Scholar
  118. 118.
    Murphy, F. J., and Zelman, S. 1965. Ascorbic acid as a urinary acidifying agent. 1. Comparison with the ketogenic effect of fasting. J. Urol. 94: 297–299.PubMedGoogle Scholar
  119. 119.
    McDonald, D. F., and Murphy, G. P. 1959. Bacteriostatic and acidifying effects of methionine, hydrolyzed casein and ascorbic acid on the urine. N. Engl. J. Med. 261: 803–805.CrossRefGoogle Scholar
  120. 120.
    Pauling, L. 1970. Vitamin C and the Common Cold. W. H. Freeman and Co., San Francisco.Google Scholar
  121. 121.
    Coulehan, J. L., Reisinger, K. S., Rogers, K. D., and Bradley, D. W. 1974. Vitamin C prophylaxis in a boarding school. N. Engl. J. Med. 290: 6–10.PubMedCrossRefGoogle Scholar
  122. 122.
    Karlowski, T. R., Chalmers, T. C., Frenkel, L. D., Kapikian, A. Z., Lewis, T. L., and Lynch, J. M. 1975. Ascorbic acid for the common cold: A prophylactic and therapeutic trial. J. Am. Med. Assoc. 231: 1038–1042.CrossRefGoogle Scholar
  123. 123.
    Coulehan, J. L., Eberhard, S., Kapner, L., Taylor, F., Rogers, K., and Garry, P. 1976. Vitamin C and acute illness in Navajo school children. N. Engl. J. Med. 295: 973–977.PubMedCrossRefGoogle Scholar
  124. 124.
    Lamden, M. P., and Chrystowski, G. A. 1954. Urinary oxalate excretion by man following ascorbic acid ingestion. Proc. Soc. Exp. Biol. Med. 85: 190–192.PubMedGoogle Scholar
  125. 125.
    Takenouchi, K., Aso, K., Kawase, K., Ichikawa, H., and Shiomi, T. 1966. On the metabolites of ascorbic acid, especially oxalic acid, eliminated in urine, following the administration of large amounts of ascorbic acid. J. Vitaminol. 12: 49–58.CrossRefGoogle Scholar
  126. 126.
    Takiguchi, H., Furuyama, S., and Shimazono, N. 1966. Urinary oxalic acid excretion by man following ingestion of large amounts of ascorbic acid. J. Vitaminol. 12: 307–312.CrossRefGoogle Scholar
  127. 127.
    Briggs, M. H., Garcia-Webb, P., and Davies, P. 1973. Urinary oxalate and vitamin-C supplements. Lancet 2: 201.PubMedCrossRefGoogle Scholar
  128. 128.
    Pak, C. Y. C. 1972. Nephrolithiasis (Ca-containing). Acta Endocrinol. Panam. 3: 45–52.Google Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Charles Y. C. Pak
    • 1
  1. 1.The University of Texas Health Science CenterDallasUSA

Personalised recommendations